The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Open accessAbstract
BACKGROUND: New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically to detect characteristic growth. METHODS: In an operational setting in Peru, we investigated the performance of the MODS assay for culture and drug-susceptibility testing in three target groups: unselected patients with suspected tuberculosis, prescreened patients at high risk for tuberculosis or multidrug-resistant tuberculosis, and unselected hospitalized patients infected with the human immunodeficiency virus. We compared the MODS assay head-to-head with two reference methods: automated mycobacterial culture and culture on Löwenstein-Jensen medium with the proportion method. RESULTS: Of 3760 sputum samples, 401 (10.7%) yielded cultures positive for Mycobacterium tuberculosis. Sensitivity of detection was 97.8% for MODS culture, 89.0% for automated mycobacterial culture, and 84.0% for Löwenstein-Jensen culture (P<0.001); the median time to culture positivity was 7 days, 13 days, and 26 days, respectively (P<0.001), and the median time to the results of susceptibility tests was 7 days, 22 days, and 68 days, respectively. The incremental benefit of a second MODS culture was minimal, particularly in patients at high risk for tuberculosis or multidrug-resistant tuberculosis. Agreement between MODS and the reference standard for susceptibility was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid (combined results for multidrug resistance), 95% for ethambutol, and 92% for streptomycin (kappa values, 1.0, 0.89, 0.93, 0.71, and 0.72, respectively). CONCLUSIONS: A single MODS culture of a sputum sample offers more rapid and sensitive detection of tuberculosis and multidrug-resistant tuberculosis than the existing gold-standard methods used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
Ransohoff, D. F., & Feinstein, A. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991705 · Cited by 1,734
Collins, L., & Franzblau, S. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1004 · Cited by 1,599
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Franzblau, S. G., Witzig, R. S., McLaughlin, J. C., Torres, P., Madico, G., Hernandez, A., Degnan, M. T., Cook, M. B., Quenzer, V. K., Ferguson, R. M., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.362-366.1998 · Cited by 964
Self-citationUse of methodological standards in diagnostic test research. Getting better but still not good
Reid, M. C. (1995) · JAMA · doi:10.1001/jama.274.8.645 · Cited by 712
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Biases in the assessment of diagnostic tests
Begg, C. B. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060402 · Cited by 496
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Caviedes, L., Lee, T.-S., Gilman, R. H., Sheen, P., Spellman, E., Lee, E. H., Berg, D. E., Montenegro-James, S., & The Tuberculosis Working Group in Peru (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1203-1208.2000 · Cited by 277
Self-citationMoore, D., Mendoza, D., Gilman, R. H., Evans, C. A., Hollm-Delgado, M.-G., Guerra, J., Caviedes, L., Vargas, D., Ticona, E., Ortiz, J., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4432-4437.2004 · Cited by 147
Self-citationReis, R. S., Neves, I., Lourenço, S. L. S., Fonseca, L. S., & Lourenço, M. C. S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2247-2248.2004 · Cited by 117
Madison, B., Robinson-Dunn, B., George, I., Gross, W., Lipman, H., Metchock, B. G., Sloutsky, A., Washabaugh, G., Mazurek, G. H., & Ridderhof, J. C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.3976-3979.2002 · Cited by 93
New diagnostic tools for tuberculosis.
Perkins, M. D. (2000) · PubMed · Cited by 89
Oberhelman, R. A., Soto-Castellares, G., Caviedes, L., Castillo, M. E., KISSINGER, P. J., Moore, D., Evans, C. A., & Gilman, R. H. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2623 · Cited by 77
Self-citationDiagnostic Evaluation of Urinary Lipoarabinomannan at an Ethiopian Tuberculosis Centre
Tsigeweini Asgedom Tessema, B. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401300077306 · Cited by 77
Multiprimer PCR system for differential identification of mycobacteria in clinical samples
Portillo, P. D., Thomas, M. C., Martínez‐Romero, E., Marañón, C., Valladares, B., Patarroyo, M. E., & López, M. C. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.2.324-328.1996 · Cited by 76
Park, W. G., Bishai, W. R., Chaisson, R. E., & Dorman, S. E. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.12.4750-4752.2002 · Cited by 67
More rigour needed in trials of new diagnostic agents for tuberculosis
Small, P. M., & Perkins, M. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02724-0 · Cited by 66
Somi, G. R., O'Brien, R. J., Mfinanga, G. S., et al. (1999) · PubMed · Cited by 51
Pachas, A. M. C., Blank, R., Fawzi, M. C. S., Bayona, J. N., Becerra, M. C., & Mitnick, C. D. (2004) · PubMed · Cited by 48
Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis.
Suffys, P. N., Palomino, J. C., Leão, S. C., Espitia, C., Cataldi, A. A., Alito, A., Velasco, M., Robledo, J., Fernández, J. O., Rosa, P. D. S., et al. (2000) · PubMed · Cited by 38
Brunello, F., & Fontana, R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.872-873.2000 · Cited by 36
Bémer, P., Bodmer, T., Munzinger, J., Perrin, M., Vincent, V., & Drugeon, H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1030-1034.2004 · Cited by 36
Kumar, M., Khan, I. A., Verma, V., & Qazi, G. N. (2005) · PubMed · Cited by 35
Diagnostic testing in the control of tuberculosis.
Perkins, M. D., & Kritski, A. L. (2002) · PubMed · Cited by 31
Tortoli, E., Mattei, R., Savarino, A., et al. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00176-0 · Cited by 31
Yew, W. W., Tong, S. C. W., Lui, K. S., Leung, S. K. F., Chau, C. H., & Wang, E. P. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00237-1 · Cited by 17
Guidelines for establishing trials of new tests to diagnose tuberculosis in endemic countries.
Walsh, A., & McNerney, R. (2004) · PubMed · Cited by 11
Pracharktam, R., Angkananukool, K., & Vibhagool, A. (2001) · PubMed · Cited by 10
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Zumla, A., Raviglione, M., Hafner, R., & Fordham von Reyn, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1200894 · Cited by 698
Metadata
- Authors
- Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., Oberhelman, R., Hollm-Delgado, M.-G., LaChira, D., Escombe, A. R., & Friedland, J. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-10-12
- Volume
- 355
- Issue
- 15
- Pages
- 1539-1550
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1976685136
- Cited by
- 468
- References
- 32
- FWCI
- 24.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.